New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
07:07 EDTAGN, MS, VRXAllergan: Executives from Morgan Stanley recently sent emails to management
Allergan (AGN) says executives from Morgan Stanley (MS), the investment bank understood to have recently been retained by Valeant (VRX), have sent emails directly to Allerganís management team that suggest they share the concerns of Allergan and third parties.
News For AGN;VRX;MS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 20, 2015
07:08 EDTMSMorgan Stanley says Q4 affected by 'choppy market conditions'
Subscribe for More Information
07:07 EDTMSMorgan Stanley reports Q4 book value of $34.62
Subscribe for More Information
07:07 EDTMSMorgan Stanley Common Equity Tier 1 risk-based capital ratio 14.2%
Subscribe for More Information
07:05 EDTMSMorgan Stanley reports Q4 continuing ops EPS 47c, consensus 48c
Subscribe for More Information
07:02 EDTMSMorgan Stanley reports Q4 EPS ex-DVA 40c, consensus 48c
Subscribe for More Information
January 16, 2015
13:51 EDTMSEarnings Preview: Morgan Stanley to report after lackluster results from peers
Subscribe for More Information
12:10 EDTMSMorgan Stanley has an active bearish pattern ahead of earnings
There is an active bearish head and shoulders pattern on the daily chart that was confirmed on a move below $35.50. Ahead of earnings the question is whether news will halt and reverse the pattern, or accelerate its completion. If the news is as bearish as traders currently expect, the pattern may continue until it reaches completion at the $31 area. If the new is more bullish than the existence of the pattern itself suggests, then a move above $35.50 would neutralize the pattern. Upside objectives to watch would be at $36.13, and $38.09.
06:56 EDTMSMorgan Stanley volatility increases into Q4 and outlook
Subscribe for More Information
05:57 EDTMSReinhart leaves Morgan Stanley as Chief U.S. economist, Bloomberg reports
Subscribe for More Information
January 15, 2015
09:14 EDTMSMorgan Stanley naming new managing directors, sources say, Reuters reports
Morgan Stanley CEO James Gorman and other senior executives have been calling employees named to the new class of managing directors at the bank, Reuters reports, citing sources. The bank is expected to make an announcement today with the names of the new managing directors. In 2014, Morgan Stanley named 153 new managing directors. Reference Link
January 13, 2015
15:12 EDTMSU.S. Supreme Court decision gives homeowners leeway to rescind mortgage loans
In an unanimous ruling, the U.S. Supreme Court ruled on Jesinoski vs. Countrywide Home Loans that homeowners are allowed to rescind home mortgages within the three years allotted under the Truth in Lending Act of 1968 by providing written notice to his/her lender. The court ruled that the borrowers were not required to file suit against the lender, which the respondents, Countrywide, claimed. The notice of rescission was sufficient to clear the homeowners of any obligation to the loan, provided they do it within the allotted time. Countrywide Home Loans is a subsidiary of Bank of America (BAC). Other publicly traded companies in the banking space include Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
14:00 EDTAGNActavis says Allergan deal could close as early as Q1, as late as Q2
Subscribe for More Information
12:49 EDTVRXValeant CEO says 'unlikely' to work with Bill Ackman again
Subscribe for More Information
12:48 EDTVRXValeant CEO says will have a 'number of clean quarters in a row'
Valeant CEO Michael Pearson said on CNBC that his company will have a "number of clean quarters in a row" in an effort to dispute attacks on its business model.
10:56 EDTVRXValeant sees continuation of Q3 trends in Q4
Subscribe for More Information
10:46 EDTVRXValeant doesn't see need to 'push a large deal for sake of doing large deal'
Sees double digit organic growth in 2014, 2015 and beyond. Says business development a priority for cash flow. Sees pursuing small and medium sized deals. Says doesn't see a need to "push a large deal for the sake of doing a large deal." Comments made at the JP Morgan Healthcare Conference. Valeant shares are up 2.1% to $158.76 in morning trading.
10:39 EDTVRXValeant repeats FY15 EPS view $10.10-$10.40, revenue $9.2B-$9.3B
Subscribe for More Information
10:38 EDTVRXValeant repeats Q4 cash EPS view $2.55+ vs. previous view $2.45-$2.55
Repeats Q4 revenue view $2.1B-$2.3B. Sees Q4 adjusted cash flow from operations about $600M. Says absorbed additional negative Fx impact of ~$40M to revenue, ~10c to cash EPS. Says FDA submission for Vesneo on track for Q2. Sees submission for sub-micron loteprednol gel 0.38% in late Q3, early Q4, and expects to launch product in 3Q16. Sees filing NDA for Arestin LCM in 2H15. Sees >12% same store organic growth for total company in Q4, >10% for FY. Sees Bausch + Lomb organic growth >10% for FY. Sees continued strong performance from Jublia, other recent product launches. Strategic initiates for 2015 include 10%-12% organic growth, cash conversion rate of >90%, achieve $500M+ revenues for key launch programs, including Jublia, Ultra, Luzu, Retin-A Micro 0.08%, Onexton. Comments from slides being presented at the JP Morgan Healthcare Conference.
07:42 EDTVRXJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
07:39 EDTVRX, AGNAmerican Academy of Cosmetic Surgery to hold a meeting
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use